The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Open accessAbstract
Obesity and diabetes have both been associated with an increased risk of cancer. In the face of increasing obesity and diabetes rates worldwide, this is a worrying trend for cancer rates. Factors such as hyperinsulinemia, chronic inflammation, antihyperglycemic medications, and shared risk factors have all been identified as potential mechanisms underlying the relationship. The most common obesity- and diabetes-related cancers are endometrial, colorectal, and postmenopausal breast cancers. In this review, we summarize the existing evidence that describes the complex relationship between obesity, diabetes, and cancer, focusing on epidemiological and pathophysiological evidence, and also reviewing the role of antihyperglycemic agents, novel research approaches such as Mendelian Randomization, and the methodological limitations of existing research. In addition, we also describe the bidirectional relationship between diabetes and cancer with a review of the evidence summarizing the risk of diabetes following cancer treatment. We conclude this review by providing clinical implications that are relevant for caring for patients with obesity, diabetes, and cancer and provide recommendations for improving both clinical care and research for patients with these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–209 of 209
de Jong, R. G. P. J., Burden, A. M., de Kort, S., van Herk‐Sukel, M. P. P., Vissers, P. A. J., Janssen, P. K. C., Haak, H. R., Masclee, A., de Vries, F., & Janssen-Heijnen, M. L. G. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.039 · Cited by 20
Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort
Park, H., Cho, S., Woo, H., Park, S. K., Shin, H., Chang, S.-H., Yoo, K., & Shin, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188465 · Cited by 20
Midlife weight gain is a risk factor for obesity-related cancer
Chadid, S., Singer, M. R., Kreger, B. E., Bradlee, M. L., & Moore, L. L. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0106-x · Cited by 19
Yeshayahu, Y., Koltin, D., Hamilton, J. K., Nathan, P. C., & Urbach, S. L. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12138 · Cited by 14
Body mass index and cancer risk among Chinese patients with type 2 diabetes mellitus
Xu, H., Zhang, M.-L., Yan, Y., Fang, F., Guo, Q., Xu, D., Zhang, Z., Zhang, F., Zhao, N., Xu, W., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4675-0 · Cited by 13
Cancer and Tuberculosis, with some Comments on Cancer and Other Diseases.
(1932) · Annals of Internal Medicine · doi:10.7326/0003-4819-5-12-1554 · Cited by 13
Ye, J., Qian, M.-H., Shi, L., & Lu, Y. (2019) · Diabetes Therapy · doi:10.1007/s13300-018-0557-3 · Cited by 11
Is risk of diabetes mellitus increased after abdominal radiotherapy?
Hawkins, M. M., Robertson, C. M., Edge, J., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91169-1 · Cited by 10
Survivorship in Adolescents and Young Adults
Kishtagari, A., Tavakkoli, M., & Park, J. H. (2014) · Acta Haematologica · doi:10.1159/000360202 · Cited by 4
Cited by
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 302
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Sjöholm, K., Carlsson, L. M. S., Svensson, P.-A., Andersson-Assarsson, J. C., Kristensson, F., Jacobson, P., Peltonen, M., & Taube, M. (2022) · Diabetes Care · doi:10.2337/dc21-1335 · Cited by 84
GLP ‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials
Silverii, G. A., Marinelli, C., Bettarini, C., Del Vescovo, G. G., Monami, M., & Mannucci, E. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16489 · Cited by 67
Pharmacological Treatment of Obesity in Older Adults
Žižka, O., Haluzík, M., & Jude, E. B. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01150-9 · Cited by 23
Metadata
- Authors
- Lega, I. C., & Lipscombe, L. L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-11-13
- Volume
- 41
- Issue
- 1
- Pages
- 33-52
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2983701642
- Cited by
- 364
- References
- 209
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.